AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AMPLIA THERAPEUTICS LTD

0.051

-0.001-1.92%

Volume:293.42K

Turnover:14.81K

Market Cap:19.79M

PE:-1.84

High:0.051

Open:0.050

Low:0.050

Close:0.052

Loading ...

Overview Company News Filings

Company Profile

Company Name:

AMPLIA THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

2000

Employees:

- -

Office Location:

350 Queen Street,Level 17,Melbourne,Victoria,Australia

Website:

http://www.ampliatx.com

Zip Code:

3000

Phone:

Fax:

61 3 9473 2555

Introduction:

Amplia Therapeutics Limited, a pharmaceutical company, focuses on advancing a pipeline of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its clinical development pipeline comprises two lead molecules, AMP945 and AMP886 that inhibits (FAK). The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","market":"AU","secType":"STK","nameCN":"AMPLIA THERAPEUTICS LTD","latestPrice":0.051,"timestamp":1747894320000,"preClose":0.052,"halted":0,"volume":293415,"delay":0,"nameEN":"AMPLIA THERAPEUTICS LTD","floatShares":278679825,"shares":387952669,"eps":-0.027671,"marketStatus":"Closed","change":-0.001,"latestTime":"05-22 16:12:00 AEST","open":0.05,"high":0.051,"low":0.05,"amount":14808,"amplitude":0.019231,"askPrice":0.051,"askSize":30000,"bidPrice":0.05,"bidSize":252461,"shortable":3,"etf":0,"ttmEps":-0.027671,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1747958400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.052,"openAndCloseTimeList":[[1747872000000,1747893600000]],"volumeRatio":0.019898,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","floatShares":278679825,"roa":"-24.61%","roe":"-44.96%","lyrEps":-0.023212,"volumeRatio":0.019898,"shares":387952669,"dividePrice":0,"high":0.051,"amplitude":0.019231,"preClose":0.052,"low":0.05,"week52Low":0.049,"pbRate":"1.55","psRate":"5.80","week52High":0.18,"institutionHeld":0,"latestPrice":0.051,"committee":0.787581,"eps":-0.027671,"divideRate":0,"volume":293415,"delay":0,"ttmEps":-0.027671,"open":0.05,"prevYearClose":0.089,"prevWeekClose":0.065,"prevMonthClose":0.049,"prevQuarterClose":0.07,"fiveDayClose":0.07,"twentyDayClose":0.052,"sixtyDayClose":0.084},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":25021935,"yearFounded":2000,"address":"350 Queen Street,Level 17,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9123 1140","officeFax":"61 3 9473 2555"},"stockCompanyDetail":{"websiteUrl":"http://www.ampliatx.com","stockEarnings":[{"period":"1week","weight":-0.0545},{"period":"1month","weight":0},{"period":"3month","weight":-0.3659},{"period":"6month","weight":-0.4091},{"period":"1year","weight":-0.1034},{"period":"ytd","weight":-0.4157}],"compareEarnings":[{"period":"1week","weight":0.0408},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0833},{"period":"6month","weight":0.1804},{"period":"1year","weight":0.1827},{"period":"ytd","weight":0.1426}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Amplia Therapeutics Limited, a pharmaceutical company, focuses on advancing a pipeline of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its clinical development pipeline comprises two lead molecules, AMP945 and AMP886 that inhibits (FAK). The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.04948},{"month":2,"riseRate":0.416667,"avgChangeRate":0.140591},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.013753},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.012909},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.111297},{"month":6,"riseRate":0.636364,"avgChangeRate":0.107904},{"month":7,"riseRate":0.636364,"avgChangeRate":0.011409},{"month":8,"riseRate":0.545455,"avgChangeRate":0.045532},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.001546},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.043056},{"month":11,"riseRate":0.545455,"avgChangeRate":-0.020316},{"month":12,"riseRate":0.5,"avgChangeRate":0.024013}],"exchange":"ASX","name":"AMPLIA THERAPEUTICS LTD","nameEN":"AMPLIA THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ATX.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-04-18","symbol":"ATX.AU","defaultRemindTime":1713398400000,"type":"split","dateTimestamp":1713362400000,"forFactor":971896,"toFactor":1000000,"ratio":0.971896}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATX.AU\",market:\"AU\",,,undefined,":[]}}